Exchange: NASDAQ·Updated 07:54 PM EDT

ARTL Artelo Biosciences Inc

$0.7172
$0.0282
(4.09%)
Today
Closed $0.7172
$0.0027
(0.38%)
After Hours
Mkt Cap$3.17M
Vol143,154.00

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
55

Bullish Sentiment

How do you feel about ARTL?

Advertisement|Remove ads.